Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 9A (PPP1R9A)

Target
PPP1R9A
Molecular classification
Regulatory subunit of protein phosphatase 1 (PP1), Scaffold protein, Cytoskeletal-associated protein, Other
01

Overview

Protein phosphatase 1 regulatory subunit 9A (PPP1R9A), also known as neurabin-1, is an actin-binding scaffolding protein that serves as a regulatory subunit of protein phosphatase 1 (PP1) and plays a key role in the organization and reorganization of the neuronal actin cytoskeleton[1][2]. The protein contains a PDZ domain and a sterile alpha motif (SAM), and is primarily expressed in neuronal tissues as well as some embryonic tissues[1]. PPP1R9A controls the formation and maturation of dendritic spines by bundling F-actin and targeting PP1 activity to specific synaptic locations, thereby modulating both structural and functional aspects of excitatory synapses[2]. Mutations and altered expression of PPP1R9A have been implicated in neurodevelopmental conditions, including autism spectrum disorder[1]. No known small-molecule drugs are reported to directly target PPP1R9A, but its critical role as a PP1 regulatory subunit and cytoskeletal scaffold protein places it at the intersection of key signaling and structural processes in neurons[1][2].

Other names
Neurabin-1Neurabin-IKIAA1222FLJ20068NRB1NRBIneural tissue-specific F-actin-binding protein INEB1
02

Mechanism of action

Selective targeting and inhibition of protein phosphatase 1 activity at synapses and in association with actin cytoskeleton[1][2]. Modulation of synaptic AMPA receptor targeting and signaling[2].

03

Biological functions

Actin cytoskeleton reorganizationF-actin binding and cross-linkingRegulation of neurite formationPromotion of dendritic filopodia formationRegulation of dendritic spine maturationSynaptic signaling and synaptic plasticityInhibition of PP1α activityOther
04

Disease associations

Autism spectrum disorderCitrullinemia, type II, neonatal-onsetNeurodevelopmental disordersOther
05

Safety considerations

Potential challenges in targeting cytoskeletal and synaptic scaffolding proteins specifically within the CNS.Broad involvement in development and synaptic function increases risk for off-target neurodevelopmental effects.

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 9A (PPP1R9A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 9A (PPP1R9A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call